The most frequent grade 3 or 4 adverse events were decreased platelet count (34 [45.3%]), decreased white blood cell count (27 [36%]), oral mucositis (10 [13.3%]), and increased alanine aminotransferase (9 [12%]). This evidence concerns the gene GPT and mucositis.